AHR and breast carcinoma: Our study was performed to explore the mechanism by which emodin acts on breast cancer cells through a comprehensive network pharmacology and experimental approach, which proved that emodin can activate AhR to inhibit the proliferation of MCF-7 cells and promote apoptosis.